The National Institutes of Health's National Institute of Allergy and Infectious Diseases established the COVID-19 Prevention Network and engaged with Oracle to develop a cloud system to identify and screen volunteers willing to participate in clinical trials.
The network aims to register millions of volunteers for large-scale testing of vaccines and monoclonal antibodies that protect people form COVID-19. In less than a week, more than 100,000 people have registered as volunteers for the clinical trials.
CoVPN expects to support hundreds of clinical trial sites in the U.S. and internationally through the end of the year. Enrollees at high risk for COVID-19 have priority participation.
Oracle built the volunteer screening registry as part of its efforts to support HHS, healthcare providers and medical researchers. In April, the company partnered with Wake Forest Baptist Health in Winston-Salem, N.C., and Javara Research to develop the Therapeutic Learning System for physicians and patients to record responses to COVID-19 drug therapies.